Primary Cutaneous CD30+/ALK- ALCL with Transition into sALCL: Favourable Response after Systemic Administration with Brentuximab Vedotin! Unique Presentation in a Bulgarian Patient!

BACKGROUND: Modern drugs could sometimes be a good solution even to problematic patients. The cutaneous and systemic forms of the CD30 positive anaplastic large T-cell lymphoma could often be described as a suitable target for therapy with Brentuximab vedotin. CASE REPORT: We present the first case...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Access Maced J Med Sci
Main Authors: Popova, Tanya Naskova, Radinov, Atanass, Stavrov, Konstantin, Temelkova, Ivanka, Terziev, Ivan, Lozev, Ilia, Lukanova, Detelina, Mangarov, Hristo, Wollina, Uwe, Tchernev, Georgi
Formato: Artigo
Idioma:Inglês
Publicado em: Republic of Macedonia 2018
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6062288/
https://ncbi.nlm.nih.gov/pubmed/30087736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3889/oamjms.2018.289
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados